MARKET

SCTL

SCTL

SOCIETAL CDMO INC
NASDAQ
1.085
-0.005
-0.46%
Opening 10:16 03/28 EDT
OPEN
1.080
PREV CLOSE
1.090
HIGH
1.090
LOW
1.080
VOLUME
114.01K
TURNOVER
0
52 WEEK HIGH
1.280
52 WEEK LOW
0.2600
MARKET CAP
114.67M
P/E (TTM)
-7.7834
1D
5D
1M
3M
1Y
5Y
Why Is Joann (JOAN) Stock Down 11% Today?
Joann (NASDAQ:JOAN) stock is falling on Monday as investors wait for the craft supplies company’s shares to be delisted following its recent bankruptcy filing. JOAN stock is down 10.6% as of Monday morning. The company will no longer be listed on the Nasdaq when markets open on Thursday. We have all of the stock market news you need to know about on Monday. Sintx Technologies stock, Societal CDMO stock and MicroAlgo stock are all down today.
Investorplace · 3d ago
Why Is Sintx Technologies (SINT) Stock Down 31% Today?
Sintx Technologies (NASDAQ:SINT) stock is down 30.6% as of Monday morning. The medical device company announced its plans for a proposed public offering of SINT shares on Friday. The company has yet to announce the pricing of the SINT stock offering. SINT is down 76.3% year-to-date.
Investorplace · 3d ago
SCTL Stock Earnings: Societal CDMO Beats Revenue for Q4 2023
Societal CDMO (NASDAQ:SCTL) just reported results for the fourth quarter of 2023. The company did not report any EPS for the quarter. Societal CD MO reported revenue of $27.72 million. This was 8.79% better than the analyst estimate for revenue.
Investorplace · 3d ago
Weekly Report: what happened at SCTL last week (0318-0322)?
Weekly Report · 3d ago
Societal Cdmo at the Crossroads: Merger with CoreRx Faces Uncertain Future and Financial Risks
Societal Cdmo faces significant uncertainty with the completion of its merger with CoreRx. Multiple conditions pose risks to the timely finalization of the transaction. The average SCTL stock price target is $1.10, implying 0.92% upside potential.
TipRanks · 4d ago
SOCIETAL CDMO INC: Annual report
Press release · 5d ago
Societal CDMO Inc reports results for the quarter ended in December - Earnings Summary
Societal CDMO Inc reports results for the quarter ended in December. Revenue rose 14.2% to $27.72 million from a year ago. The company reported a quarterly adjusted loss of 1 cent per share. Societal CD MO Inc shares had risen by 202.4% this quarter.
Reuters · 5d ago
Weekly Report: what happened at SCTL last week (0311-0315)?
Weekly Report · 03/18 09:57
More
About SCTL
Societal CDMO, Inc. is a bi-coastal contract development and manufacturing organization (CDMO). The Company is engaged in spanning pre-investigational new drug development to commercial manufacturing and packaging for a range of therapeutic dosage forms with a primary focus on the area of small molecules. It is involved in CDMO providing therapeutic development, end-to-end regulatory support, clinical and commercial manufacturing, aseptic fill/finish, lyophilization, packaging and logistics services to the global pharmaceutical market. The Company’s products include Ritalin LA, Focalin XR, Verelan PM, Verelan SR, Verapamil PM, Verapamil SR, Donnatal liquids and tablets and Scot-Tussin cough and cold liquids. Its manufacturing and development capabilities include product development from formulation through clinical trial and commercial manufacturing, and specialized capabilities for solid oral dosage forms and facilities to handle highly potent compounds and controlled substances.

Webull offers Societal CDMO Inc stock information, including NASDAQ: SCTL real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SCTL stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading SCTL stock methods without spending real money on the virtual paper trading platform.